Skip to main content
. 2018 Nov;59(5):535–547. doi: 10.1165/rcmb.2018-0049TR

Table 2.

Interstitial Lung Disease Injury Patterns Associated with Common Tyrosine Kinase Inhibitors

Drug
Injury Pattern
Gefitinib DAD, HP, IP, alveolar hemorrhage
Erlotinib BO, HP
Sorafenib BO, COP, IP
Imatinib IP

Definition of abbreviations: BO = bronchiolitis obliterans; COP = cryptogenic organizing pneumonia; DAD = diffuse alveolar damage; HP = hypersensitivity pneumonitis; IP = interstitial pneumonia.